Fitero, A.; Negrut, N.; Popa, A.; John, H.T.; Ferician, A.C.; Manole, F.; Marian, P.
Integrated Analysis of Remdesivir and Paxlovid in COVID-19 Patients: A Personalized Approach to High-Risk Individuals for Severe Evolution. J. Clin. Med. 2024, 13, 6670.
https://doi.org/10.3390/jcm13226670
AMA Style
Fitero A, Negrut N, Popa A, John HT, Ferician AC, Manole F, Marian P.
Integrated Analysis of Remdesivir and Paxlovid in COVID-19 Patients: A Personalized Approach to High-Risk Individuals for Severe Evolution. Journal of Clinical Medicine. 2024; 13(22):6670.
https://doi.org/10.3390/jcm13226670
Chicago/Turabian Style
Fitero, Andreea, Nicoleta Negrut, Anca Popa, Harrie Toms John, Anca Cristina Ferician, Felicia Manole, and Paula Marian.
2024. "Integrated Analysis of Remdesivir and Paxlovid in COVID-19 Patients: A Personalized Approach to High-Risk Individuals for Severe Evolution" Journal of Clinical Medicine 13, no. 22: 6670.
https://doi.org/10.3390/jcm13226670
APA Style
Fitero, A., Negrut, N., Popa, A., John, H. T., Ferician, A. C., Manole, F., & Marian, P.
(2024). Integrated Analysis of Remdesivir and Paxlovid in COVID-19 Patients: A Personalized Approach to High-Risk Individuals for Severe Evolution. Journal of Clinical Medicine, 13(22), 6670.
https://doi.org/10.3390/jcm13226670